SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Medplus Health Services Ltd (MEDPLUS)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 543427 NSE: MEDPLUS Retailing | Small Cap | Medplus Health Serv. Share Price

₹701.55 11.00 (1.59%)

As on 07-Aug'26 12:25

Medplus Health Services Ltd (MEDPLUS)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 543427 NSE: MEDPLUS Retailing | Small Cap | Medplus Health Serv. Share Price

₹701.55 11.00 (1.59%)

As on 07-Aug'26 12:25

Key Metrics
Valuation Multiples
Market Cap
₹8,296 Cr.
Current Price
₹701.6
52-Week Low / High
₹654 / 1,020
TTM EPS
₹5.5
TTM Sales
₹899 Cr.
Book Value per Share
₹110.3
P/E Ratio
125.07
Lower than its 3-year historical median
Industry PE
68
Price to Book (P/B)
6.26
Lower than its 5-year historical median
Price to Sales (P/S)
9.22
Lower than its 5-year historical median
EV/EBITDA
66.04
Lower than its 5-year historical median
Dividend Yield
0%
Profitability Efficiency
Return on Equity (ROE)
4.95%
Underperforms industry median
Return on Capital Employed (ROCE)
7.16%
Underperforms industry median
Return on Assets (ROA)
4.32%
Operating Profit Margin
12.5%
Net Profit Margin
7.25%
Gross Profit Margin
11.7%
Growth Momentum
1-yr vs 3-yr growth
Sales Growth (1 Year)
Slowing versus 3-year growth rate
20.68%
Operating Profit Growth (1 Year)
Slowing versus 3-year growth rate
37.67%
Net Profit Growth (1 Year)
Slowing versus 3-year growth rate
54.71%
Asset Quality
Promoter Holding
40.19%
Pledged shares (%) of Promoter's holding (%)
60.74%
Reserves
₹1,302 Cr.
Equity
₹24 Cr.
Face Value
₹2
All Time Low / High
₹570.00 / 1343.00

Medplus Health Services stock performance

Key Ratios
mw4me loader

Check Before You Invest

Valuation

Undervalued

Price Trend

Weak
Q.1 Is Medplus Health Services Ltd a good quality company?
Medplus Health Services Ltd is a weak quality company, based on a inconsistent multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

We have analysed the performance of the company on the following:

  • How has it performed on generating Profits?

    By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.

  • How efficiently has it utilized Capital?

    By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.

  • How is it managing its Debt?

    By checking its Debt to Equity and Cash Flow from Operations.

How does Medplus Health Services Ltd performance compare with that of its Peers?
Q.1 Revenue growth of Medplus Health Services Ltd vs industry peers?
Medplus Health Services Ltd revenue CAGR is 65.98%, compared to the industry median CAGR of 0%, indicating faster growth and gaining its market share.
Q.1 Promoter shareholding and pledge status of Medplus Health Services Ltd?
Promoters hold 40.19% of the Medplus Health Services Ltd, with 60.74% of their stake pledged, indicating high pledge risk.
Q.1 Stock return of Medplus Health Services Ltd over the last decade?
Over the last 3 year(s), the stock has delivered a CAGR of -9.96% based on the current price.

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Medplus Health Services Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25Mar'26TTM
ROCE % -1.3%-2.3%-1.4%-8.3%-1.8%1%1.3%1.3%4.9%7.2%-
Value Creation
Index
-1.1-1.2-1.1-1.6-1.1-0.9-0.9-0.9-0.6-0.5-

Growth Parameters

Sales 2.29.49.561.168.3146214467713861899
Sales YoY Gr.-336.1%1.1%541.9%11.8%113.3%46.8%118.3%52.7%20.7%-
Adj EPS -10.3-70.6-11.2-9.9-37.40.50.50.83.45.25.5
YoY Gr.-NANANANANA-2.2%75.6%326.6%54.9%-
BVPS (₹) 437.3821.2809.11,772.82,09392.393.195.6101.4109110.3
Adj Net
Profit
-2-16.2-2.6-2.3-8.65.55.49.540.362.766
Cash Flow from Ops. -1.7-1.1-0.92.9-6.2-18.411.47.746.762-
Debt/CF from Ops. -25.3000000000-

CAGR

9 Years 5 Years 3 Years 1 Years
Sales 94.5%66%59%20.7%
Adj EPS NANA126.4%54.9%
BVPS-14.3%-44.6%5.4%7.4%
Share Price - - -9.7% -16.2%

Key Financial Parameters

Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25Mar'26TTM
Return on
Equity %
-1.8-11.3-1.4-0.8-1.90.70.50.83.34.95
Op. Profit
Mgn %
-89.3-51.6-36.411.7-12.92.32.96.910.912.512.5
Net Profit
Mgn %
-90.1-171.5-27-3.7-12.53.72.525.77.37.4
Debt to
Equity
0.5000000000-
Working Cap
Days
7941541566111680757771869364
Cash Conv.
Cycle
-39-72-1572267383932353952

Valuation of Medplus Health Serv. - Standalone

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Analyst's Notes

data not found
No data found!

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *54.1754.1754.1755.2059.3459.3459.3460.7460.7460.74
* Pledged shares as % of Promoter's holding (%)

Financials

PARTICULARSMar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25Mar'26
Sales29106168146214467713861
Operating Expenses + 414138677142208435635753
Manufacturing Costs1122014101214
Material Costs0004450119157351547652
Employee Cost 2447231428444754
Other Costs 298344919302933
Operating Profit -2-5-3-25-9363278107
Operating Profit Margin (%) -89.3%-51.6%-36.4%-41.2%-12.9%2.3%2.9%6.9%10.9%12.4%
Other Income + 0112210237911
Exceptional Items 0000000000
Interest 01200137898
Depreciation 00011515242726
Profit Before Tax -2-16-3-24-96875183
Tax 0001002-31121
Profit After Tax -2-16-3-25-96694062
PAT Margin (%) -90.1%-171.0%-27.0%-40.7%-12.5%3.8%2.6%2.0%5.7%7.3%
Adjusted EPS (₹)-10.3-74.1-11.8-114.0-38.30.50.50.83.45.2
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%0%
PARTICULARSMar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25Mar'26

Equity and Liabilities

Shareholders Fund + 951791773874691,1011,1111,1571,2141,308
Share Capital 1200002424242424
Reserves 831791763874681,0781,0871,1331,1901,284
Debt +43000000000
Long Term Debt43000000000
Short Term Debt0000000000
Minority Interest0000000000
Trade Payables13512613184534
Others Liabilities 44710287781150133148140
Total Liabilities 1831891924165481,1871,2741,3081,4071,482

Fixed Assets

Net Fixed Assets +00072385179192184167
Gross Block22192692201238252258
Accumulated Depreciation22123722466891
CWIP 000121618012
Investments 177181186381409418917923928931
Inventories0004547141827
Trade Receivables012912213870122133
Cash Equivalents 04111877906357139
Others Assets 43231263625479684
Total Assets 1831891924165481,1871,2741,3081,4071,482
PARTICULARSMar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25Mar'26
Cash Flow From Operating Activity + -2-1-13-6-181184762
PBT -2-16-3-24-96875183
Adjustment 012031813313129
Changes in Working Capital 021-5-6-232-27-27-29
Tax Paid -02010-2-2-2-9-22
Cash Flow From Investing Activity + 0-2-3-197-15-63632-24-39-22
Capex -0-0-0-3-12-37-61-11-9-6
Net Investments 00000-599543-17-36-25
Others 0-2-3-194-20-450459
Cash Flow From Financing Activity + -07020497569-8-6-10-5
Net Proceeds from Shares 0701059417510
Net Proceeds from Borrowing 0-000000000
Interest Paid -0-0000-3-7-8-9-8
Dividend Paid 0000000000
Others 00020397-23-3-5-6-6
Net Cash Flow -14-41076-8635-22-235
PARTICULARSMar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25Mar'26
Ratios
ROE (%)-2.1-12.34-1.44-8.83-20.710.50.833.44.95
ROCE (%)-1.27-2.29-1.39-8.3-1.751.011.251.324.937.16
Asset Turnover Ratio0.010.050.050.20.150.180.190.390.570.65
PAT to CFO Conversion(x)N/AN/AN/AN/AN/A-31.830.891.181
Working Capital Days
Receivable Days22.3012.4050.5031.5052.5038.4046.6038.7045.1049.40
Inventory Days22.105.407.2012.3022.8010.208.407.507.608.80
Payable Days00026.7012.6012.2021.301621.1022.20

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Medplus Health Services Ltd FAQs

The current trading price of Medplus Health Serv. on 07-Aug-2026 12:25 is ₹701.5.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 06-Aug-2026 the market cap of Medplus Health Serv. stood at ₹8,296.1 Cr

The latest P/E ratio of Medplus Health Serv. as of 06-Aug-2026 is 125.1.

The latest P/B ratio of Medplus Health Serv. as of 06-Aug-2026 is 6.26.

The 52-week high of Medplus Health Serv. is ₹1,020.4 and the 52-week low is ₹653.8.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Medplus Health Serv. is ₹899 ( Cr.) .

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Medplus Health Services Ltd is a below average quality company.

The key valuation ratios of Medplus Health Services Ltd's currently when compared to its past seem to suggest it is in the Undervalued zone.

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Medplus Health Services Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

About Medplus Health Services Ltd

Medplus Health Services offers a wide range of products, including (i) pharmaceutical and wellness products, including medicines, vitamins, medical devices and test kits, and (ii) fast-moving consumer goods, such as home and personal care products, including toiletries, baby care products, soaps and detergents, and sanitizers. The company was founded in 2006 by Gangadi Madhukar Reddy, its Managing Director and Chief Executive Officer, with the vision to set up a trusted pharmacy retail brand that offers genuine medicines and delivers better value to the customer by reducing inefficiencies in the supply chain using technology.

The company employs a data analytics driven cluster-based approach to its store network expansion, whereby it first achieve high store density in a densely-populated residential area within a target city before expanding its store network in the surrounding areas within that city, followed by expansion into other adjacent cities. Its cluster-based approach to store network expansion is also driven by its understanding of the catchment demographics, market dynamics, and its ability to support store expansion with back-end infrastructure, such as warehouses and distribution centres. This approach and understanding allow it to (i) create brand visibility within the cities where it operate, through focused implementation of marketing and advertising initiatives, (ii) increase its market share in the cities where it operate, (iii) replicate its growth model in adjacent underserved cities and towns, as it develop its presence in those clusters, and (iv) generate cost efficiencies due to operating leverage achieved in its supply chain and inventory management. It has a streamlined and methodical store opening process, and dedicated operations and business development teams at the area, city and state levels that would vet and approve the opening of new stores.

Business area of the company

MedPlus is one of India's leading healthcare companies with an ever-growing number of pharmacy stores, online pharmacy, path labs and optical services.

Awards, accreditations and recognitions

  • 2012: VC Circle Awards - Best VC-backed Healthcare Services Company.
  • 2017: Hans India - hmtv Business Excellence Award - Best in Retail category.

Major events and milestones

  • 2007: Pharmaceutica Ventures Limited invested Rs 800 million, by subscribing to 45,720 equity shares, Peepul Capital Fund II LLC invested Rs 226.33 million by subscribing to 30,000 equity shares of the Company and NEA-IndoUS Venture Capital LLC invested $5 million by subscribing to 11,620 equity shares of our Company (out of which 4,662 equity shares through conversion of Series A CCPS.)
  • 2012: EBITDA of the Company turned positive.
  • 2017: Gangadi Investments Private Limited acquired 122,347 equity shares, 12,000,000 unlisted redeemable preference shares and 42,847,000 non-convertible debentures from MKCP Direct Investments (Mauritius) IV Limited, MKCP Institutional Investor (Mauritius) III Limited, TVS Shriram Growth Fund IA and Indiaventure Trust -Fund I.
  • 2019: PI Opportunities Fund - I invested acquiring 22.21% stake of the Company as on date, pursuant to purchase of 21,233 equity shares.
  • 2021: Lavender Rose invested Rs 6.56 billion, acquiring a 24.58% stake of the Company as on date through primary and secondary transactions.
  • 2021: PI Opportunities Fund - I invested Rs 222.10 million by subscribing to 160,147 Series C2 CCPS.
You have 4 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: